The genetic risk factors for pregnancy-induced hypertension: Evidence from genetic polymorphisms.
Wenwen WeiXin WangYuanzhong ZhouXuejun ShangHong-Song YuPublished in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology (2022)
Pregnancy-induced hypertension (PIH) is a multifactorial and severe pregnancy complication including preeclampsia/eclampsia, gestational hypertension, chronic (pre-existing) hypertension, and preeclampsia/eclampsia variants superimposed on chronic hypertension. PIH-induced maternal mortality accounts for approximately 9% of all maternal deaths over the world. A large number of case-control studies have established the importance of various genetic factors in the occurrence and development of PIH. In this narrative review, we summarized the genetic risk factors involved in the renin-angiotensin system, endothelin system, inflammatory factors, oxidative stress, and other functional networks, with the aim of sorting out the genetic factors that may play a potential role in PIH and providing new ideas to elucidate the pathogenesis of PIH.
Keyphrases
- pregnancy outcomes
- blood pressure
- diabetic rats
- oxidative stress
- early onset
- risk factors
- case control
- copy number
- drug induced
- high glucose
- pregnant women
- preterm birth
- birth weight
- risk assessment
- dna damage
- type diabetes
- weight gain
- cardiovascular events
- gene expression
- arterial hypertension
- body mass index
- stress induced